Ornithine transcarbamylase deficiency and pregnancy: A case series and review of recommendations
- PMID: 35601507
- PMCID: PMC9117120
- DOI: 10.1016/j.crwh.2022.e00390
Ornithine transcarbamylase deficiency and pregnancy: A case series and review of recommendations
Abstract
Background: Ornithine transcarbamylase deficiency (OTCD) is a rare disorder of the urea cycle that obstetricians should be aware of in order to guide management for pregnant carriers of the X-linked gene that causes the condition.
Cases: We present the pregnancy management and outcomes of two women with OTCD. The particular manifestations of the disease drive antenatal, intrapartum and postpartum management.
Conclusion: Preconception counseling, early prenatal diagnostics and multidisciplinary intrapartum and postpartum management plans contribute to improved outcomes for patients.
© 2022 The Authors.
Similar articles
-
Management of ornithine transcarbamylase deficiency in pregnancy.Am J Perinatol. 2010 Nov;27(10):775-84. doi: 10.1055/s-0030-1254240. Epub 2010 May 10. Am J Perinatol. 2010. PMID: 20458665 Review.
-
Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review.Am J Med Genet A. 2019 Oct;179(10):2091-2100. doi: 10.1002/ajmg.a.61329. Epub 2019 Aug 22. Am J Med Genet A. 2019. PMID: 31441224
-
Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With OTC Mutations.Front Pediatr. 2020 Jul 23;8:321. doi: 10.3389/fped.2020.00321. eCollection 2020. Front Pediatr. 2020. PMID: 32793520 Free PMC article.
-
Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.Am J Emerg Med. 2015 Mar;33(3):474.e1-3. doi: 10.1016/j.ajem.2014.08.038. Epub 2014 Aug 23. Am J Emerg Med. 2015. PMID: 25227973
-
Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.BMC Gastroenterol. 2022 Mar 28;22(1):144. doi: 10.1186/s12876-022-02213-0. BMC Gastroenterol. 2022. PMID: 35346058 Free PMC article.
Cited by
-
Perinatal management and follow-up in a child with a prenatal diagnosis of OTC deficiency: a case report.Front Nutr. 2024 Sep 30;11:1416466. doi: 10.3389/fnut.2024.1416466. eCollection 2024. Front Nutr. 2024. PMID: 39403401 Free PMC article.
-
Considerations for prenatal and postpartum management of a female patient with ornithine transcarbamylase deficiency.Mol Genet Metab Rep. 2022 Jul 12;33(Suppl 1):100894. doi: 10.1016/j.ymgmr.2022.100894. eCollection 2022 Dec. Mol Genet Metab Rep. 2022. PMID: 36620386 Free PMC article.
-
Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency.Children (Basel). 2023 Aug 9;10(8):1368. doi: 10.3390/children10081368. Children (Basel). 2023. PMID: 37628367 Free PMC article. Review.
References
-
- Torkzaban M., Haddad A., Baxter J.K., Berghella V., Gahl W.A., Al-Kouatly H.B. Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: a systematic review. Am. J. Med. Genet. A. 2019;179(10):2091–2100. doi: 10.1002/ajmg.a.61329. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources